Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides
Charlie Saillard1, Benoit Schmauch1, Oumeima Laifa1
1Owkin Lab, Owkin, Paris, France.
Hepatology (Baltimore, Md.)
|February 29, 2020
Summary
Artificial intelligence (AI) models using deep learning on whole-slide images can predict survival in hepatocellular carcinoma (HCC) patients after surgery. These AI tools improve prognostic accuracy, aiding treatment decisions for liver cancer.
Area of Science:
- Digital pathology
- Artificial intelligence in oncology
- Hepatocellular carcinoma research
Background:
- Standardized risk stratification is crucial for hepatocellular carcinoma (HCC) treatment strategies.
- Accurate prognosis is needed to evaluate adjuvant therapies post-resection/ablation for HCC.
Purpose of the Study:
- To develop and validate deep-learning algorithms for predicting survival in HCC patients undergoing surgical resection.
- To compare the performance of AI models against traditional prognostic scores.
Main Methods:
- Two deep-learning algorithms (SCHMOWDER and CHOWDER) were developed using whole-slide imaging (WSI) of digitized histological slides.
- Models were trained on a discovery set (n=194) and validated on an independent set (TCGA, n=328).
- Feature extraction involved dividing WSIs into tiles and using a pretrained convolutional neural network; SCHMOWDER incorporated pathologist-annotated tumoral areas.
Main Results:
- Deep-learning models achieved high c-indices for survival prediction (SCHMOWDER: 0.78, CHOWDER: 0.75) in the discovery set.
- Both AI models demonstrated superior predictive performance compared to a composite score of baseline variables in both discovery and validation sets.
- Pathological analysis identified vascular spaces, macrotrabecular pattern, and lack of immune infiltration as key indicators of poor survival.
Conclusions:
- Artificial intelligence significantly enhances the prediction of HCC prognosis.
- The integration of pathologist expertise with machine learning algorithms improves AI model development and biological interpretability.
- AI-driven risk stratification can refine therapeutic strategies for HCC patients.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
438
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
1.3K
